Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Loncar China BioPharma ETF CHNA
$17.92
+$0.01 (0.04%)
На 18:01, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
22.89
-
week52low
13.35
-
Revenue
-
P/E TTM
0
-
Beta
0.00000000
-
EPS
0.00000000
-
Last Dividend
3.22600000
-
Next Earnings Date
07 мая 2023 г. в 02:54
Описание компании
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
What Lies Ahead for China ETFs in the Year of Rabbit?
Zacks Investment Research
23 янв 2023 г. в 14:18
The Chinese markets have recently made a comeback. Can the rally last in the year of water rabbit?
China: Timing Of Recovery Is A Big Question Mark
Seeking Alpha
10 янв 2023 г. в 09:05
China has drastically eased its Covid-19 measures. Both domestic mobility and international traffic should increase in 2023.
China ETFs Lead the Way in This Week's Top Performing ETFs
ETF Trends
09 янв 2023 г. в 20:10
This week's top-performing ETFs include five China-focused strategies, a far cry from the panic that China would be uninvestable following the Fall's Chinese Communist Party Congress. Led by the top ETF based on one-week returns, the Global X MSCI China Real Estate ETF (CHIR) at 18.
China's Economy: Don't Get Your Hopes Up Just Yet
Seeking Alpha
04 янв 2023 г. в 13:54
Most global economists feel that any recovery in China could be more U-shaped than V-shaped. The 2022 Chinese economy can best be described as a spluttering car engine.
Top-Performing ETF Areas of Last Week
Zacks Investment Research
03 янв 2023 г. в 15:47
Wall Street recorded a moderate performance last week. But the final week of the year was not that bad.